Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 716 (USA) (Dr. Ito)
· consented 2013-06-08
Adverse events
3
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild FATIGUE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-13 (study day 36.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild HYPERSOMNIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-13 (study day 36.0); relationship: POSSIBLE
moderate
assessed
2026-08-18
Moderate SYNCOPE — outcome: RECOVERED/RESOLVED; onset 2013-07-31 (study day 54.0); relationship: PROBABLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.